• 176: AI, Innovation, and the Future of Pharma Meetings ft. Pierre Metrailler

  • Mar 28 2025
  • Length: 58 mins
  • Podcast

176: AI, Innovation, and the Future of Pharma Meetings ft. Pierre Metrailler

  • Summary

  • In this episode of the Events Demystified Podcast⁠, host Anca Platon Trifan, CMP, WMEP⁠ sits down with Pierre Metrailler, CEO of SpotMe and Onomi, to discuss the current landscape and future of pharma event technology. They talk about the inefficiencies in current event methodologies, the integration of AI and automation, and the importance of education and engagement in medical meetings. Pierre also shares his personal journey and extensive experience in transforming pharma customer engagement through innovative technology solutions.

    Key takeaways include the importance of moving beyond traditional models to more interactive and engaging formats, the crucial role of compliance, and the potential of AI to reshape the industry.

    Don't miss this essential conversation for anyone involved in the pharma or life sciences space.


    GUEST BIO

    Pierre Metrailler is an event technology pioneer with over 20 years of experience. After joining SpotMe in 2001, he expanded the company's vision from hardware-based networking devices to comprehensive event engagement solutions. He led the company's transformation to a SaaS platform in 2011, with a strong focus on enterprise customers. As CEO since 2016, Pierre has pursued a CRM-first strategy and addressed critical industries' unmet needs, launching Onomi, a customer engagement platform for life sciences. He holds degrees from the Swiss Federal Institute of Technology, Lausanne and INSEAD.


    🔍 Topics Covered:

    • 00:00 Introduction: Pharma Event Spending
    • 01:51 Meet the Innovator: Pierre Metrailler
    • 03:19 Pierre's Adventurous Spirit and Leadership Lessons
    • 06:31 The Journey of SpotMe
    • 10:02 Leadership Insights: The Salt Shaker Theory
    • 15:11 Understanding Pharma Meetings
    • 21:28 The Evolution of Pharma Meetings
    • 29:07 A Memorable Event Experience
    • 30:34 Challenges in Adopting New Technologies
    • 32:54 Compliance in Pharma Events
    • 35:21 Innovative Solutions for Pharma Meetings
    • 42:23 The Role of AI in Pharma Events
    • 45:55 Introducing Onomi: Streamlining Pharma Events
    • 53:36 Advice for Pharma Event Planners
    • 55:52 Conclusion and Final Thoughts


    Connect with our Guest at the links below:

    • Pierre Metrailler’s LinkedIn https://www.linkedin.com/in/pierremetrailler/


    Connect with your Podcast Host at the links below:

    • Speaker website: https://ancaplatontrifan.me/
    • LinkedIn: ⁠https://www.linkedin.com/in/ancatrifan/⁠
    • Instagram: ⁠https://www.instagram.com/anca.platon.trifan
    • Instagram: https://www.instagram.com/fit.mindful.maven/
    • Instagram: https://www.instagram.com/eventsdemystifiedpodcast/

    Follow the podcast on Spotify, and/or Instagram, LinkedIn page, and our YouTube page to stay updated on the latest episodes, behind the scenes reels, and join the conversation.


    “Events: demystified” Podcast is brought to you by Tree-Fan Events, a leading woman-owned boutique event planning and production agency offering a comprehensive approach to event management and production, with a focus on enhancing the attendee experience with the #FIT4EVENTS framework for a holistic event cycle in order to create memorable events.


    ⁠⁠Original Podcast Music written and produced by ⁠⁠⁠⁠⁠⁠⁠⁠Fable Score Music.

    Show More Show Less
activate_mytile_page_redirect_t1

What listeners say about 176: AI, Innovation, and the Future of Pharma Meetings ft. Pierre Metrailler

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.